1. Minimally invasive surgery: national trends in adoption and future directions for hospital strategy;Tsui;Surg Endosc,2013
2. Practice Bulletin No. 149: Endometrial cancer;Obstet Gynecol,2015
3. U.S. Food and Drug Administration. FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids. December 2017. Silver Spring, MD. Available at: https://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/UCM584539.pdf. Accessed August 14, 2018.
4. Management of uterine fibroids. Comparative Effectiveness Review No. 195. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2015-00003-I.) AHRQ Publication No. 17(18)-EHC028-EF;Hartmann,2017
5. Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy;Andy;J Minim Invasive Gynecol,2014